▶ 調査レポート

世界のカルボプラチン注射液市場 2021:企業別、地域別、種類・用途別

• 英文タイトル:Global Carboplatin Injection Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

GlobalInfoResearchが調査・発行した産業分析レポートです。世界のカルボプラチン注射液市場 2021:企業別、地域別、種類・用途別 / Global Carboplatin Injection Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026 / GIR-111D11365資料のイメージです。• レポートコード:GIR-111D11365
• 出版社/出版日:GlobalInfoResearch / 2021年10月
• レポート形態:英文、PDF、105ページ
• 納品方法:Eメール(納期:2~3日)
• 産業分類:医薬品
• 販売価格(消費税別)
  Single User¥459,360 (USD3,480)▷ お問い合わせ
  Multi User¥689,040 (USD5,220)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
当調査資料では、カルボプラチン注射液のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。カルボプラチン注射液の種類別市場規模(10ml:50mg、10ml:100mg、その他)、用途別市場規模(卵巣がん、乳がん、SCLC、その他)、地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど)、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。
・カルボプラチン注射液の市場概要
・企業情報(企業概要、製品概要、販売量、価格、売上):Hospira(Pfizer)、Bristol-Myers Squibb SA、Teva、Mylan、Taj Pharmaceuticals、Fresenius Kabi、Qilu Pharmaceutical、Cisen Pharmaceutical、Yunnan Phytopharmaceutical、Hisun、Jiangsu Lianhuan Pharmaceutical、Yangzijiang Group、Shandong Ruiying、Shanghai Acebright Pharmaceuticals
・企業別市場シェア
・地域別市場分析2016年-2026年
・種類別分析2016年-2026年:10ml:50mg、10ml:100mg、その他
・用途別分析2016年-2026年:卵巣がん、乳がん、SCLC、その他
・カルボプラチン注射液の北米市場規模2016年-2026年:アメリカ、カナダ、メキシコ
・カルボプラチン注射液のヨーロッパ市場規模2016年-2026年:ドイツ、イギリス、フランス、ロシア、イタリア
・カルボプラチン注射液のアジア市場規模2016年-2026年:中国、日本、韓国、インド、東南アジア、オーストラリア
・カルボプラチン注射液の南米市場規模2016年-2026年:ブラジル、アルゼンチン
・カルボプラチン注射液の中東・アフリカ市場規模2016年-2026年:サウジアラビア、トルコ、エジプト、南アフリカ
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Carboplatin Injection market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Carboplatin Injection size is estimated to be xx million in 2021 from USD xx million in 2020, with a change of XX% between 2020 and 2021. The global Carboplatin Injection market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation
Carboplatin Injection market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
10ml:50mg
10ml:100mg
Other

Market segment by Application can be divided into
Ovarian Cancer
Breast Cancer
SCLC
Other

The key market players for global Carboplatin Injection market are listed below:
Hospira(Pfizer)
Bristol-Myers Squibb SA
Teva
Mylan
Taj Pharmaceuticals
Fresenius Kabi
Qilu Pharmaceutical
Cisen Pharmaceutical
Yunnan Phytopharmaceutical
Hisun
Jiangsu Lianhuan Pharmaceutical
Yangzijiang Group
Shandong Ruiying
Shanghai Acebright Pharmaceuticals

Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe Carboplatin Injection product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Carboplatin Injection, with price, sales, revenue and global market share of Carboplatin Injection in 2018 and 2019.
Chapter 3, the Carboplatin Injection competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Carboplatin Injection breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Carboplatin Injection market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe Carboplatin Injection sales channel, distributors, customers, research findings and conclusion, appendix and data source.

レポート目次

1 Market Overview
1.1 Carboplatin Injection Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Carboplatin Injection Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 10ml:50mg
1.2.3 10ml:100mg
1.2.4 Other
1.3 Market Analysis by Application
1.3.1 Overview: Global Carboplatin Injection Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Ovarian Cancer
1.3.3 Breast Cancer
1.3.4 SCLC
1.3.5 Other
1.4 Global Carboplatin Injection Market Size & Forecast
1.4.1 Global Carboplatin Injection Sales in Value (2016-2026))
1.4.2 Global Carboplatin Injection Sales in Volume (2016-2026)
1.4.3 Global Carboplatin Injection Price by Type (2016-2026) & (US$/Unit)
1.5 Global Carboplatin Injection Production Capacity Analysis
1.5.1 Global Carboplatin Injection Total Production Capacity (2016-2026)
1.5.2 Global Carboplatin Injection Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Carboplatin Injection Market Drivers
1.6.2 Carboplatin Injection Market Restraints
1.6.3 Carboplatin Injection Trends Analysis
2 Manufacturers Profiles
2.1 Hospira(Pfizer)
2.1.1 Hospira(Pfizer) Details
2.1.2 Hospira(Pfizer) Major Business
2.1.3 Hospira(Pfizer) Carboplatin Injection Product and Services
2.1.4 Hospira(Pfizer) Carboplatin Injection Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 Bristol-Myers Squibb SA
2.2.1 Bristol-Myers Squibb SA Details
2.2.2 Bristol-Myers Squibb SA Major Business
2.2.3 Bristol-Myers Squibb SA Carboplatin Injection Product and Services
2.2.4 Bristol-Myers Squibb SA Carboplatin Injection Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.3 Teva
2.3.1 Teva Details
2.3.2 Teva Major Business
2.3.3 Teva Carboplatin Injection Product and Services
2.3.4 Teva Carboplatin Injection Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.4 Mylan
2.4.1 Mylan Details
2.4.2 Mylan Major Business
2.4.3 Mylan Carboplatin Injection Product and Services
2.4.4 Mylan Carboplatin Injection Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.5 Taj Pharmaceuticals
2.5.1 Taj Pharmaceuticals Details
2.5.2 Taj Pharmaceuticals Major Business
2.5.3 Taj Pharmaceuticals Carboplatin Injection Product and Services
2.5.4 Taj Pharmaceuticals Carboplatin Injection Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.6 Fresenius Kabi
2.6.1 Fresenius Kabi Details
2.6.2 Fresenius Kabi Major Business
2.6.3 Fresenius Kabi Carboplatin Injection Product and Services
2.6.4 Fresenius Kabi Carboplatin Injection Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.7 Qilu Pharmaceutical
2.7.1 Qilu Pharmaceutical Details
2.7.2 Qilu Pharmaceutical Major Business
2.7.3 Qilu Pharmaceutical Carboplatin Injection Product and Services
2.7.4 Qilu Pharmaceutical Carboplatin Injection Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.8 Cisen Pharmaceutical
2.8.1 Cisen Pharmaceutical Details
2.8.2 Cisen Pharmaceutical Major Business
2.8.3 Cisen Pharmaceutical Carboplatin Injection Product and Services
2.8.4 Cisen Pharmaceutical Carboplatin Injection Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.9 Yunnan Phytopharmaceutical
2.9.1 Yunnan Phytopharmaceutical Details
2.9.2 Yunnan Phytopharmaceutical Major Business
2.9.3 Yunnan Phytopharmaceutical Carboplatin Injection Product and Services
2.9.4 Yunnan Phytopharmaceutical Carboplatin Injection Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.10 Hisun
2.10.1 Hisun Details
2.10.2 Hisun Major Business
2.10.3 Hisun Carboplatin Injection Product and Services
2.10.4 Hisun Carboplatin Injection Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.11 Jiangsu Lianhuan Pharmaceutical
2.11.1 Jiangsu Lianhuan Pharmaceutical Details
2.11.2 Jiangsu Lianhuan Pharmaceutical Major Business
2.11.3 Jiangsu Lianhuan Pharmaceutical Carboplatin Injection Product and Services
2.11.4 Jiangsu Lianhuan Pharmaceutical Carboplatin Injection Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.12 Yangzijiang Group
2.12.1 Yangzijiang Group Details
2.12.2 Yangzijiang Group Major Business
2.12.3 Yangzijiang Group Carboplatin Injection Product and Services
2.12.4 Yangzijiang Group Carboplatin Injection Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.13 Shandong Ruiying
2.13.1 Shandong Ruiying Details
2.13.2 Shandong Ruiying Major Business
2.13.3 Shandong Ruiying Carboplatin Injection Product and Services
2.13.4 Shandong Ruiying Carboplatin Injection Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.14 Shanghai Acebright Pharmaceuticals
2.14.1 Shanghai Acebright Pharmaceuticals Details
2.14.2 Shanghai Acebright Pharmaceuticals Major Business
2.14.3 Shanghai Acebright Pharmaceuticals Carboplatin Injection Product and Services
2.14.4 Shanghai Acebright Pharmaceuticals Carboplatin Injection Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 Carboplatin Injection Sales by Manufacturer
3.1 Global Carboplatin Injection Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Carboplatin Injection Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Carboplatin Injection
3.4 Market Concentration Rate
3.4.1 Top 3 Carboplatin Injection Manufacturer Market Share
3.4.2 Top 6 Carboplatin Injection Manufacturer Market Share
3.5 Global Carboplatin Injection Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Carboplatin Injection Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Carboplatin Injection Market Size by Region
4.1.1 Global Carboplatin Injection Sales in Volume by Region (2016-2026)
4.1.2 Global Carboplatin Injection Revenue by Region (2016-2026)
4.2 North America Carboplatin Injection Revenue (2016-2026)
4.3 Europe Carboplatin Injection Revenue (2016-2026)
4.4 Asia-Pacific Carboplatin Injection Revenue (2016-2026)
4.5 South America Carboplatin Injection Revenue (2016-2026)
4.6 Middle East and Africa Carboplatin Injection Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Carboplatin Injection Sales in Volume by Type (2016-2026)
5.2 Global Carboplatin Injection Revenue by Type (2016-2026)
5.3 Global Carboplatin Injection Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Carboplatin Injection Sales in Volume by Application (2016-2026)
6.2 Global Carboplatin Injection Revenue by Application (2016-2026)
6.3 Global Carboplatin Injection Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Carboplatin Injection Sales by Type (2016-2026)
7.2 North America Carboplatin Injection Sales by Application (2016-2026)
7.3 North America Carboplatin Injection Market Size by Country
7.3.1 North America Carboplatin Injection Sales in Volume by Country (2016-2026)
7.3.2 North America Carboplatin Injection Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Carboplatin Injection Sales by Type (2016-2026)
8.2 Europe Carboplatin Injection Sales by Application (2016-2026)
8.3 Europe Carboplatin Injection Market Size by Country
8.3.1 Europe Carboplatin Injection Sales in Volume by Country (2016-2026)
8.3.2 Europe Carboplatin Injection Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Carboplatin Injection Sales by Type (2016-2026)
9.2 Asia-Pacific Carboplatin Injection Sales by Application (2016-2026)
9.3 Asia-Pacific Carboplatin Injection Market Size by Region
9.3.1 Asia-Pacific Carboplatin Injection Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Carboplatin Injection Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Carboplatin Injection Sales by Type (2016-2026)
10.2 South America Carboplatin Injection Sales by Application (2016-2026)
10.3 South America Carboplatin Injection Market Size by Country
10.3.1 South America Carboplatin Injection Sales in Volume by Country (2016-2026)
10.3.2 South America Carboplatin Injection Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Carboplatin Injection Sales by Type (2016-2026)
11.2 Middle East & Africa Carboplatin Injection Sales by Application (2016-2026)
11.3 Middle East & Africa Carboplatin Injection Market Size by Country
11.3.1 Middle East & Africa Carboplatin Injection Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Carboplatin Injection Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Carboplatin Injection Typical Distributors
12.3 Carboplatin Injection Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer